학술논문

A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia
Document Type
Journal
Source
BLOOD; JUN 15 2004, 103 12, p4659-p4665, 7p.
Subject
Language
English
ISSN
00064971